Home > Press > Purdue gains $14.9 million in NIH funding to expand Bindley Bioscience Center
Bindley Bioscience Center researchers Allison Dill, in foreground, and Livia Eberlin analyze molecular fingerprint signatures gathered from a miniature mass spectrometer combined with a technique called desorption electrospray ionization, known as DESI. The device and technique, developed by team led by Purdue professor R. Graham Cooks, will be an essential research tool for the planned Multidisciplinary Cancer Research Facility. (Purdue University photo/Vincent Walter) |
Abstract:
Purdue has received $14.9 million in funding from the National Institutes of Health to expand Discovery Park's Bindley Bioscience Center for growing its cancer and life sciences research.
By Phillip Fiorini
The NIH's National Center for Research Resources is awarding the money through a federal stimulus measure for the 29,000-square-foot expansion to establish the Multidisciplinary Cancer Research Facility at Purdue. The addition will house investigators from the National Cancer Institute-designated Purdue University Center for Cancer Research to work on innovative animal models of disease, development of new therapeutics and in-vivo animal imaging.
"This major Bindley Bioscience Center expansion addresses a critical need for disease researchers from across multiple disciplines at Purdue," said biology professor Richard Kuhn, director of the Bindley Bioscience Center and head of the Department of Biological Sciences. "This also builds on the university's strengths in cancer research, drug discovery and development, engineering, chemistry and instrumentation, and veterinary medicine with a disease research-focused, multidisciplinary facility for biomedical research."
Thirty to 40 new positions will be created to direct and carry out federally funded research activities at the facility, which will be designed to achieve silver level Leadership in Energy and Environmental Design (LEED) certification, Kuhn said.
Planning and project design for the addition on the south side of the existing building is already under way, Kuhn said. About 165 jobs also will be created during construction, which is expected to begin in August 2011. Completion is tentatively set for April 2013.
"The expansion will complement the capabilities of Bindley and the Purdue University Center for Cancer Research in biophysical and biomolecular analyses, conventional cell imaging and separation, and high-throughput screening technologies," said Timothy Ratliff, the Robert Wallace Miller Director of the Purdue University Center for Cancer Research. "Laboratories are planned for cancer cell biology, therapeutic and medical device development, cell-based screening, medicinal chemistry, and next-generation imaging."
With Bindley's proximity to the Birck Nanotechnology Center, the addition also broadens Purdue's efforts in nanomedicine, which uses nanotechnology for advancing diagnosis and treatment of cancer and other diseases, Ratliff said.
"This National Institutes of Health funding builds on Purdue and Indiana's success in advancing bio- and life-science research, helping create jobs, and increasing the competitiveness of the state's work force," said Richard O. Buckius, Purdue vice president for research. "A larger Bindley Bioscience Center also helps position Indiana to gain a larger share of $14 billion market for life sciences research and development, an industry segment that's growing 15 percent a year."
Bindley Bioscience Center is named for 1962 Purdue graduate William E. Bindley, who in 2002 contributed $52.5 million to the university. Bindley designated $7.5 million of his gift to cover half the cost of the two-story, 50,000-square-foot research facility, with the rest funded by earnings from unrestricted endowments. The center opened to researchers in October 2005.
Lilly Endowment Inc. provided $50 million to launch Discovery Park, which has grown into a $500 million interdisciplinary research complex for large-scale projects. An arm of Purdue's research enterprise, Discovery Park brings scientists, researchers, engineers and management experts together to make basic discoveries available to advance Indiana's economy and solve societal problems by developing new products and processes.
The Purdue University Center for Cancer Research, one of only seven basic science NCI-designated cancer centers, will begin its 32nd year of NCI funding in July 2010.
####
For more information, please click here
Contacts:
Writer:
Phillip Fiorini
765-496-3133
Sources:
Richard Kuhn
765-494-4407
Timothy Ratliff
765-494-9129
Richard Buckius
765-494-6209
Copyright © Purdue University
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Openings/New facilities/Groundbreaking/Expansion
OCSiAl expands its graphene nanotube production capacities to Europe June 17th, 2022
GLOBALFOUNDRIES Moves Corporate Headquarters to its Most Advanced Semiconductor Manufacturing Facility in New York April 27th, 2021
Oxford Instruments Plasma Technology relocates to advanced manufacturing facility: Move driven by exceptional business growth February 12th, 2021
Jobs
Could quantum technology be New Mexico’s next economic boon? Quantum New Mexico Coalition aims to establish state as national hub April 1st, 2022
SEMI Partners with GLOBALFOUNDRIES to Offer Apprenticeship Program Aimed at Building the Electronics Talent Pipeline August 11th, 2020
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) March 29th, 2019
Govt.-Legislation/Regulation/Funding/Policy
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Single atoms show their true color July 5th, 2024
Academic/Education
Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024
Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Atomic force microscopy in 3D July 5th, 2024
Aston University researcher receives £1 million grant to revolutionize miniature optical devices May 17th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||